1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2016. CA Cancer J Clin. 2016;66:7-30.
https://doi.org/10.3322/caac.21332
PMid:26742998

2. Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66:271-89.
https://doi.org/10.3322/caac.21349
PMid:27253694

3. Zhang D, Xu X, Dong Z. PRKCD/PKCδ contributes to nephrotoxicity during cisplatin chemotherapy by suppressing autophagy. Autophagy. 2017;13:631-632.
https://doi.org/10.1080/15548627.2016.1269990
PMid:28059582 PMCid:PMC5361607

4. Rehammar JC, Jensen MB, Mcgale P, Lorenzen EL, Taylor C, Darby SC, et al. Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977–2005. Radiother Oncol. 2017;123:299-305.
https://doi.org/10.1016/j.radonc.2017.03.012
PMid:28365142 PMCid:PMC5446317

5. Gotwals P, Cameron S, Cipolletta D, Cremasco V, Crystal A, Hewes B, et al. Prospects for combining targeted and conventional cancer therapy with immunotherapy. Nat Rev Cancer. 2017;17:286-301.
https://doi.org/10.1038/nrc.2017.17
PMid:28338065

6. McNutt M. Cancer Immunotherapy. Science. 2013;342:1417.
https://doi.org/10.1126/science.1249481
PMid:24357273

7. Palucka AK, Coussens LM. The Basis of Oncoimmunology. Cell. 2016;164:1233-1247.
https://doi.org/10.1016/j.cell.2016.01.049
PMid:26967289 PMCid:PMC4788788

8. Schumacher TN, Schreiber RD. Neoantigens in cancer immunotherapy. Science. 2015;348:69-74.
https://doi.org/10.1126/science.aaa4971
PMid:25838375

9. Rosenberg SA, Restifo NP. Adoptive cell transfer as personalized immunotherapy for human cancer. Science. 2015;348:62-8.
https://doi.org/10.1126/science.aaa4967
PMid:25838374

10. Qiu L, Li J, Yu S, Wang Q, Li Y, Hu Z, et al. A novel cancer immunotherapy based on the combination of a synthetic carbohydrate-pulsed dendritic cell vaccine and glycoengineered cancer cells. Oncotarget. 2015;6:5195-203.
https://doi.org/10.18632/oncotarget.2908
PMid:25760071 PMCid:PMC4467142

11. Tran E, Turcotte S, Gros A, Robbins PF, Lu YC, Dudley ME, et al. Cancer Immunotherapy Based on Mutation-Specific CD4+T Cells in a Patient with Epithelial Cancer. Science. 2014;344:641-5.
https://doi.org/10.1126/science.1251102
PMid:24812403

12. Kalinski P, Muthuswamy R, Urban J. Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies. Expert Rev Vaccines. 2013;12:285-95.
https://doi.org/10.1586/erv.13.22
PMid:23496668

13. Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ. Dendritic cell immunotherapy: mapping the way. Nat Med. 2004;10:475-80.
https://doi.org/10.1038/nm1039
PMid:15122249

14. Palucka K, Banchereau J. Dendritic-cell-based therapeutic cancer vaccines. Immunity. 2013;39:38-48.
https://doi.org/10.1016/j.immuni.2013.07.004
PMid:23890062 PMCid:PMC3788678

15. Hovden AO, Appel S. The First Dendritic Cell-Based Therapeutic Cancer Vaccine is Approved by the FDA. Scand J Immunol. 2010;72:554.
https://doi.org/10.1111/j.1365-3083.2010.02464.x
PMid:21044130

16. Nestle FO, Banchereau J, Hart D. Dendritic cells: On the move from bench to bedside. Nat Med. 2001;7:761-5.
https://doi.org/10.1038/89863
PMid:11433329

17. Palucka K, Banchereau J. Cancer immunotherapy via dendritic cells. Nat Rev Cancer. 2012;12:265-77.
https://doi.org/10.1038/nrc3258
PMid:22437871 PMCid:PMC3433802

18. Sun Z, Wang W, Meng J, Chen S, Xu H, Yang XD. Multi-walled carbon nanotubes conjugated to tumor protein enhance the uptake of tumor antigens by human dendritic cells in vitro. Cell Res. 2010;20:1170-3.
https://doi.org/10.1038/cr.2010.133
PMid:20838419

19. Motamedi M, Arab S, Moazzeni SM, Khamis Abadi M, Hadjati j. Improvement of a Dendritic Cell-Based Therapeutic Cancer Vaccine with Components of Toxoplasma gondii. Clin Vaccine Immunol. 2009;16:1393-8.
https://doi.org/10.1128/CVI.00199-09
PMid:19656994 PMCid:PMC2756855

20. Szeto GL, Van Egeren D, Worku H, Sharei A, Alejandro B, Park C, et al. Microfluidic squeezing for intracellular antigen loading in polyclonal B-cells as cellular vaccines. Sci Rep. 2015;5:10267.
https://doi.org/10.1038/srep10276
PMid:25999171 PMCid:PMC4441198

21. Wang J, Guo J, Wu S, Feng H, Sun S, Pan J, et al. Synergistic Effects of Nanosecond Pulsed Electric Fields Combined with Low Concentration of Gemcitabine on Human Oral Squamous Cell Carcinoma In Vitro. Plos One. 2012;7:e43213.
https://doi.org/10.1371/journal.pone.0043213
PMid:22927951 PMCid:PMC3426536

22. Hassan HA, Smyth L, Wang JT, Costa PM, Ratnasothy K, Diebold SS, et al. Dual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapy. Biomaterials. 2016;104:310-22.
https://doi.org/10.1016/j.biomaterials.2016.07.005
PMid:27475727 PMCid:PMC4993816

23. Nuccitelli R, Pliquett U, Chen X, Ford W, James Swanson R, Beebe SJ, et al. Nanosecond pulsed electric fields cause melanomas to self-destruct. Biochem Biophys Res Commun. 2006:343;351-60.
https://doi.org/10.1016/j.bbrc.2006.02.181
PMid:16545779 PMCid:PMC1513546

24. Tekle E, Oubrahim H, Dzekunov SM, Kolb JF, Schoenbach KH, Chock PB. Selective field effects on intracellular vacuoles and vesicle membranes with nanosecond electric pulses. Biophys J. 2005;89:274-84.
https://doi.org/10.1529/biophysj.104.054494
PMid:15821165 PMCid:PMC1366525

25. Satkauskas S, Andre F, Bureau MF, Scherman D, Miklavcic D, Mir LM. Electrophoretic component of electric pulses determines the efficacy of In Vivo DNA electrotransfer. Hum Gene Ther. 2005;16:1194-201.
https://doi.org/10.1089/hum.2005.16.1194
PMid:16218780

26. Yu JS, Liu G, Ying H, Yong WH, Black KL, Wheeler CJ. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Cancer Res. 2004;64:4973-9.
https://doi.org/10.1158/0008-5472.CAN-03-3505
PMid:15256471